Multi-drug resistance mediated by P-glycoprotein overexpression is not correlated with ZAP-70/CD38 expression in B-cell chronic lymphocytic leukemia

Leukemia and Lymphoma

Volumn 48, Issue 8, 2007, Pages 1556-1560

  Guillaume, Nicolas ^a   Gouilleux Gruart, Valérie ^b   Claisse, Jean François ^a   Troussard, Xavier ^c   Lepelley, Pascale ^d   Damaj, Gandhi ^a   Royer, Bruno ^a   Garidi, Reda ^a   Lefrere, Jean Jacques ^a  

^a AMIENS UNIVERSITY HOSPITAL   (France)

^b INSERM   (France)

^c CAEN UNIVERSITY HOSPITAL   (France)

^d LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

CD38; Chronic lymphocytic leukemia; Multidrug resistance; Rhodamine 123; ZAP 70

Indexed keywords

CD38 ANTIGEN; GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN 1; PROTEIN KINASE ZAP 70;

ADULT; AGED; ARTICLE; B CELL LEUKEMIA; CANCER STAGING; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN CELL; MALE; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

EID: 34547993284     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190701457931     Document Type: Article

References (15)

1. Chan, A. C., Iwashima, M., Turck, C. W. and Weiss, A. (1992) ZAP-70: A 70 kd protein-tyrosine kinase that associates with the TCR ζ chain. Cell, 71, pp. 649-662.
2. Guillaume, N., Alleaume, C., Munfus, D., Capiod, J. C., Touati, G. and Pautard, B. (2005) ZAP-70 tyrosine kinase is constitutively expressed and phosphorylated in B-lineage acute lymphoblastic leukemia cells. Haematologica, 90, pp. 899-905.
3. Nolz, J. C., Tschumper, R. C., Pittner, B. T., Darce, J. R., Kay, N. E. and Jelinek, D. F. (2005) ZAP-70 is expressed by a subset of normal human B-lymphocytes displaying an activated phenotype. Leukemia, 19, pp. 1018-1024.
4. Wiestner, A., Rosenwald, A., Barry, T. S., Wright, G., Davis, R. E. and Henrickson, S. E. (2003) ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile. Blood, 101, pp. 4944-4951.
5. Rassenti, L. Z., Huynh, L., Toy, T. L., Chen, L., Keating, M. J. and Gribben, J. G. (2004) ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia. N Engl Med J, 351, pp. 893-901.
6. Damle, R. N., Wasil, T., Fais, F., Ghiotto, F., Valetto, A. and Allen, S. L. (1999) Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood, 94, pp. 1840-1847.
7. Chen, L., Apgar, J., Huynh, L., Dicker, F., Giago-McGahan, T. and Rassenti, L. (2005) ZAP-70 directly enhances IgM signaling in chronic lymphocytic leukemia. Blood, 105, pp. 2036-2041.
8. Castro, J. E., Prada, C. E., Loria, O., Kamal, A., Chen, L. and Burrows, F. J. (2005) ZAP-70 is a novel conditional heat shock protein 90 (Hsp90) client: Inhibition of Hsp90 leads to ZAP-70 degradation, apoptosis, and impaired signaling in chronic lymphocytic leukemia. Blood, 106, pp. 2506-2512.
9. Richardson, S. J., Matthews, C., Catherwood, M. A., Alexander, H. D., Carey, B. S. and Farrugia, J. (2005) ZAP-70 expression is associated with enhanced ability to respond to migratory and survival signals in B cell chronic lymphocytic leukemia (B-CLL). Blood, 107, pp. 3584-3592.
10. Maynadie, M., Matutes, E. and Catovsky, D. (1997) Quantification of P-glycoprotein in chronic lymphocytic leukemia by flow cytometry. Leuk Res, 21, pp. 825-831.
11. Schroers, R., Griesinger, F., Trumper, L., Haase, D., Kulle, B. and Klein-Hitpass, L. (2005) Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia. Leukemia, 19, pp. 750-758.
12. Michelutti, A., Michieli, M., Damiani, D., Melli, C., Ermacora, A. and Grimaz, S. (1997) Effect of fludarabine and arabinosylcytosine on multidrug resistant cells. Haematologica, 82, pp. 143-147.
13. Aleskog, A., Tobin, G., Laurell, A., Thunberg, U., Lindhagen, E. and Roos, G. (2004) VH gene mutation status and cellular drug resistance in chronic lymphocytic leukemia. Eur J Haematol, 73, pp. 407-411.
14. Campos, L., Guyotat, D., Archimbaud, E., Calmard-Oriol, P., Tsuruo, T. and Troncy, J. (1992) Clinical significance of multidrug resistance P-glycoprotein expression on acute nonlymphoblastic leukemia cells at diagnosis. Blood, 79, pp. 473-476.
15. Svoboda-Beusan, I., Kusec, R., Bendelja, K., Tudoric-Ghemo, I., Jaksic, B. and Pejsa, V. (2000) The relevance of multidrug resistance-associated P-glycoprotein expression in the treatment response of B-cell chronic lymphocytic leukemia. Haematologica, 85, pp. 1261-1267.